Pro Share Advisors LLC Cara Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$36.7 Billion
Q1 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$4.89 - $12.27 $6,332 - $15,889	-1,295 Reduced 11.24%	10,229 $50,000
Q4 2022 Feb 02, 2023	BUY	$8.88 - $12.77 $7,423 - $10,675	836 Added 7.82%	11,524 $123,000
Q3 2022 Nov 04, 2022	BUY	$8.24 - $12.56 $2,208 - $3,366	268 Added 2.57%	10,688 $100,000
Q2 2022 Aug 01, 2022	SELL	$7.45 - $13.84 $36,512 - $67,829	-4,901 Reduced 31.99%	10,420 $95,000
Q1 2022 May 10, 2022	SELL	$9.94 - $12.65 $32,145 - $40,910	-3,234 Reduced 17.43%	15,321 $186,000

Q4 2021 Feb 08, 2022	BUY	$11.99 - $18.14 $12,889 - $19,500	1,075 Added 6.15%	18,555 $226,000
Q3 2021 Nov 12, 2021	SELL	$11.55 - $16.06 $48,613 - $67,596	-4,209 Reduced 19.41%	17,480 $270,000
Q2 2021 Aug 13, 2021	BUY	$12.38 - $29.19 $47,254 - $111,418	3,817 Added 21.36%	21,689 $310,000
Q1 2021 May 14, 2021	BUY	$15.07 - $21.71 $16,019 - $23,077	1,063 Added 6.32%	17,872 $388,000
Q4 2020 Feb 09, 2021	BUY	$12.72 - $16.16 $53,525 - $68,001	4,208 Added 33.39%	16,809 $254,000
Q3 2020 Nov 13, 2020	SELL	$12.34 - $17.92 $5,799 - $8,422	-470 Reduced 3.6%	12,601 $160,000
Q2 2020 Aug 03, 2020	BUY	$12.39 - $17.33 $161,949 - $226,520	13,071 New	13,071 $224,000
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $141,332 - $275,536	-15,497 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$16.11 - $25.98 $25,840 - $41,671	-1,604 Reduced 9.38%	15,497 $250,000
Q3 2019 Nov 12, 2019	BUY	$18.28 - $26.91 $37,437 - $55,111	2,048 Added 13.61%	17,101 $313,000
Q2 2019 Aug 13, 2019	SELL	$17.68 - $21.57 $33,362 - $40,702	-1,887 Reduced 11.14%	15,053 $324,000
Q1 2019 May 15, 2019	BUY	$14.41 - $19.64 $1,988 - $2,710	138 Added 0.82%	16,940 $332,000
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $39,889 - $75,197	-3,204 Reduced 16.02%	16,802 $218,000
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $47,316 - $64,497	2,693 Added 15.55%	20,006 $479,000
Q2 2018 Aug 13, 2018	SELL	$11.6 - $19.27 $13,664 - $22,700	-1,178 Reduced 6.37%	17,313 $332,000
Q1 2018 May 14, 2018	SELL	$11.77 - $16.08 $35,816 - $48,931	-3,043 Reduced 14.13%	18,491 $229,000
Q4 2017 Feb 14, 2018	BUY	$11.86 - $14.08 $255,393 - $303,198	21,534	21,534 $264,000

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

Black Rock Inc. New York, NY

3.42M
Shares

$889,554
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.48M
Shares

$645,127
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.82M
Shares

$471,915
0.03% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$442,548
0.15% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$404,625
0.01% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account